Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exatecan mesylate + Gemcitabine in Advanced Pancreatic Cancer
NCT00023972Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2001
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of exatecan in pancreatic cancer (PC), sponsored by Daiichi Sankyo Co., Ltd.. Started Jul 2001; status: completed.
02
Drugs
exatecan
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00023972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00023972.